Menu

This Flu Season Killed 172 Kids

Vaccination reduced the risk of death by two-thirds for children with no other health problems.  

Jun 11, 2018
Sukanya Charuchandra

ISTOCK, PEOPLEIMAGESThe Centers for Disease Control and Prevention’s US influenza survey published on June 8 reports the death of one more child, bringing the current tally to 172. This is the highest number reported since the CDC began registering pediatric deaths, except for the H1N1 pandemic that killed 358 children in 2009.


According to The Washington Post, Daniel Jernigan, head of the CDC’s influenza division, says this season was “bad across the population.” The CDC’s new classification system for flu seasons categorized the 2017-18 flu as “high severity” across all ages. “It was happening to everyone, and it seemed to be happening everywhere,” Jernigan adds.


The CDC concocts a new vaccine every year based on predictions of seasonal strains. Despite the CDC’s flu vaccine recommendations, only 38.8 percent of children between the ages of 6 months and 17 years received the immunization this season.


The flu vaccine “reduced the risk of death among children by half for any kids who had underlying medical conditions, and by nearly two-thirds for otherwise healthy children,” Alicia Bird, an epidemiologist in the CDC’s influenza division, tells TIME.


Delays in reporting flu-related deaths to the CDC means the actual number may yet be higher, reports Huffington Post.


See “How Bad Will the Flu Season Get? Forecasters Are Competing to Figure it Out

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!